RIEMSER Arzneimittel GmbH   Report issue

For profit Phase 1 Phase 2
Founded: Greifswald Germany (1999)
Status: Acquired by Esteve Labs (2020)

Organization Overview

First Clinical Trial
1999
NCT01429090
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Riemser